Search results
Pfizer Stock Gets Boost From Better-Than-Expected Earnings
Investopedia· 6 days agoThe company posted adjusted net income, which doesn't account for items such as impact of...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via AOL· 5 days ago...Massachusetts-based biopharmaceutical company said its sales decline “aligns with the anticipated...
Pfizer profits drop on lower Covid-19 product sales
AFP via Yahoo Finance· 6 days agoPfizer reported a drop in profits on lower sales of Covid-19 related profits Wednesday as it steers investments to other pharmaceutical areas and...
UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters via Yahoo Finance· 1 day agoGermany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday that almost ...
Earnings call: Pfizer raises 2024 EPS outlook despite revenue decline By Investing.com
Investing.com· 6 days agoDespite a 19% decline in total company revenues to $14.9 billion, primarily due to the reduced...
Pfizer Inc (PFE) Q1 2024 Earnings: Adjusted EPS Surpasses Expectations Amidst Revenue Decline
GuruFocus.com via Yahoo Finance· 6 days agoStrategic and Operational Highlights Despite the challenges posed by declining COVID-19 product...
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 6 days agoSales of Padcev, a treatment for advanced bladder cancer Pfizer gained through its $43 billion deal...
Supreme Court rejected military chaplains' lawsuit saying their careers were ruined after refusing...
Business Insider· 6 days agoThe Supreme Court denied military chaplains' lawsuit claiming retaliation for refusing the COVID-19 ...
Pfizer Announces New Chief Strategy and Innovation Officer
Morningstar· 1 day agoPfizer Inc. (NYSE: PFE) today announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation Officer, Executive Vice President. Dr. Baum will be ...
Pfizer’s first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Market Watch· 6 days agoAn expected drop in COVID-19-related product sales, including antiviral Paxlovid and vaccine...